OCULAR THERAPEUTIX, INC — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OCULAR THERAPEUTIX, INC (OCUL)
CIK: 0001393434
Period of Report: 2021-06-18

Reporting Person: Williams Leslie J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-18	Stock Option (Right to Buy)	$13.51	A	18000	Acquired	2031-06-17	Common Stock (18000)	Direct

Footnotes

F1: Vests with respect to 100% of the securities on the first anniversary of the grant date.